Oryzon shoots up 22% on the stock market after announcing an agreement with the US National Cancer Institute.

Oryzon shoots up 22% on the stock market after announcing an agreement with the US National Cancer Institute.

MADRID, July 19 (EUROPA PRESS) – Oryzon Genomics has soared almost 22% on the stock market at the close of the session after announcing the signing of a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI). English) of the United States to carry out further clinical development of the LSD1 inhibitor …

Oryzon shoots up 22% on the stock market after announcing an agreement with the US National Cancer Institute. Read More »